Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors

CONCLUSIONS: The diversity of pathways predicted to be affected by the diversity in miRNA expression after treatment with PIs paves the way for the recognition of new regulatory axes in BrCa.PMID:38038871 | DOI:10.1007/s12094-023-03349-5

Source: Clinical Breast Cancer - December 1, 2023 Category: Cancer & Oncology Authors: Katerina Katsaraki Christos K Kontos Gerasimos Ardavanis-Loukeris Alexandros A Tzovaras Diamantis C Sideris Andreas Scorilas Source Type: research